Evaluation of the cancer stem cell characteristics of acquired resistant BT549 GEM100nM breast cancer cells

Tawari Erebi Patricia

doi:10.30574/ijsra.2024.13.2.2442

ISSN Approved Journal || eISSN: 2582-8185 || CODEN: IJSRO2 || Impact Factor 8.2 || Google Scholar and CrossRef Indexed

Peer Reviewed and Referred Journal || Free Certificate of Publication

Research and review articles are invited for publication in March 2026 (Volume 18, Issue 3) Submit manuscript

Evaluation of the cancer stem cell characteristics of acquired resistant BT549 GEM100nM breast cancer cells

Tawari Erebi Patricia ^*

Department of Chemical Pathology, Faculty of Basic Clinical Sciences, College of Health Science, Niger Delta University, Bayelsa State, Nigeria.

Research Article

International Journal of Science and Research Archive, 2024, 13(02), 2428–2434.
Article DOI: 10.30574/ijsra.2024.13.2.2442
DOI url: https://doi.org/10.30574/ijsra.2024.13.2.2442

Publication history

Received on 28 October 2024; revised on 04 December 2024; accepted on 07 December 2024

Abstract

Stem cells playing a vital role in cancer biology have drawn more attention in recent years. Many dense cancers, involving the breast, brain, colon, liver, and pancreas, have been found to be associated with cancer stem cells (CSCs). The objective of this research is to evaluate the cancer stem markers of an attained resistant BT549 GEM100nM breast cancer cell line. Fluorescence-activated cell sorting (FASC) results showed that the resistant cell lines contained higher levels of embryonic markers (Nanog, Oct 4, and Sox2) and cancer stem cell markers (ALDH and CD 133) than the parental wild-type cell (BT549). It is thought that these CSC indicators are pivotal for cancer genesis, relapse, spread and treatment resistance.

Keywords

Cancer stem cells; Resistant cell lines; Stem cell markers; Embryonic cell markers

Download Article PDF

https://ijsra.net/sites/default/files/fulltext_pdf/IJSRA-2024-2442.pdf

Preview Article PDF

How to cite this article

Tawari Erebi Patricia. Evaluation of the cancer stem cell characteristics of acquired resistant BT549 GEM100nM breast cancer cells. International Journal of Science and Research Archive, 2024, 13(02), 2428–2434. https://doi.org/10.30574/ijsra.2024.13.2.2442

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.

All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.